Investigation Overview
An investigation on behalf of investors of Myriad Genetics, Inc. (NASDAQ: MYGN) shares over potential securities laws violations by Myriad Genetics, Inc. and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Myriad Genetics, Inc. (...
You must register (for free) or login to view the entire investigation.